Shares of Valneva SE (NASDAQ:VALN – Get Rating) gapped down before the market opened on Wednesday . The stock had previously closed at $13.48, but opened at $12.40. Valneva shares last traded at $12.40, with a volume of 1 shares trading hands.
Analyst Upgrades and Downgrades
Several analysts have issued reports on the stock. Kepler Capital Markets cut shares of Valneva from a “buy” rating to a “hold” rating in a research note on Thursday, July 28th. HC Wainwright reduced their target price on shares of Valneva from $34.00 to $32.00 and set a “buy” rating on the stock in a report on Friday, August 19th.
Valneva Price Performance
The company has a quick ratio of 0.94, a current ratio of 1.16 and a debt-to-equity ratio of 0.72. The firm’s fifty day simple moving average is $18.61 and its 200-day simple moving average is $24.48.
Hedge Funds Weigh In On Valneva
Several hedge funds have recently modified their holdings of VALN. UBS Group AG purchased a new position in shares of Valneva in the second quarter worth $31,000. Jane Street Group LLC lifted its holdings in shares of Valneva by 85.9% in the first quarter. Jane Street Group LLC now owns 16,584 shares of the company’s stock worth $569,000 after buying an additional 7,664 shares in the last quarter. Finally, Bank of America Corp DE purchased a new position in shares of Valneva in the first quarter worth $858,000. Hedge funds and other institutional investors own 16.39% of the company’s stock.
Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; DUKORAL, an oral vaccine for the prevention of diarrhea caused by Vibrio cholera and/or heat-labile toxin producing Enterotoxigenic Escherichia coli bacterium; and VLA2001, a vaccine candidate against SARS-CoV-2.
- Get a free copy of the StockNews.com research report on Valneva (VALN)
- The Institutions Hold On To Darden Restaurants International
- What Steelcase’s Earnings Say About the Return to the Office?
- Is The Golden Age Of Homebuilding Already Over?
- These 3 Big Dividend Payers Also Boast Strong Price Growth
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
Receive News & Ratings for Valneva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Valneva and related companies with MarketBeat.com's FREE daily email newsletter.